BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36357104)

  • 1. Intestinal
    Rahim S; Alkhaldi SS; Alasousi K; Ali RH
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36357104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
    Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A
    Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
    Haller F; Knopf J; Ackermann A; Bieg M; Kleinheinz K; Schlesner M; Moskalev EA; Will R; Satir AA; Abdelmagid IE; Giedl J; Carbon R; Rompel O; Hartmann A; Wiemann S; Metzler M; Agaimy A
    J Pathol; 2016 Apr; 238(5):700-10. PubMed ID: 26863915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoid Spindle Cell Sarcoma With
    So YK; Chow C; To KF; Chan JKC; Cheuk W
    Int J Surg Pathol; 2020 Aug; 28(5):574-578. PubMed ID: 32050835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle cell tumor with CD34 and S100 co-expression and distinctive stromal and perivascular hyalinization showing EML4-ALK fusion.
    Abs D; Landman S; Osio A; Lepesant P; Schneider P; Obadia D; Moguelet P; Farges C; Poirot B; Lehmann-Che J; Lebbé C; Battistella M
    J Cutan Pathol; 2021 Jul; 48(7):896-901. PubMed ID: 33241586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary NTRK -rearranged Spindle Cell Neoplasm of the Gastrointestinal Tract: A Clinicopathological and Molecular Analysis of 8 Cases.
    Gao X; Xu S; Zhu P; Lao IW; Yu L; Wang J
    Am J Surg Pathol; 2024 May; 48(5):623-631. PubMed ID: 38525823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization.
    Lopez-Nunez O; Surrey LF; Alaggio R; Fritchie KJ; John I
    Genes Chromosomes Cancer; 2020 Aug; 59(8):495-499. PubMed ID: 32222087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.
    Agaram NP; Zhang L; Sung YS; Chen CL; Chung CT; Antonescu CR; Fletcher CD
    Am J Surg Pathol; 2016 Oct; 40(10):1407-16. PubMed ID: 27259011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans.
    Panse G; Reisenbichler E; Snuderl M; Wang WL; Laskin W; Jour G
    J Cutan Pathol; 2021 Feb; 48(2):290-294. PubMed ID: 32519338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAF1-rearranged spindle cell tumour: report of two additional cases with identification of a novel FMR1-RAF1 fusion.
    Zhang T; Wang Q; Yi X; Zhu P
    Virchows Arch; 2021 Dec; 479(6):1245-1253. PubMed ID: 34459981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100 and CD34 positive spindle cell tumor with prominent perivascular hyalinization and a novel NCOA4-RET fusion.
    Michal M; Ptáková N; Martínek P; Gatalica Z; Kazakov DV; Michalová K; Stoláriková L; Švajdler M; Michal M
    Genes Chromosomes Cancer; 2019 Sep; 58(9):680-685. PubMed ID: 30938880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of spindle cell tumors with S100 and CD34 co-expression showing novel RAF1 fusions.
    Gong LH; Liu WF; Niu XH; Ding Y
    Diagn Pathol; 2022 Oct; 17(1):80. PubMed ID: 36229858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low-grade malignant soft tissue tumor with S100 and CD34 co-expression showing novel CDC42SE2-BRAF fusion with distinct features.
    Sheng SJ; Li JM; Zou YF; Peng XJ; Wang QY; Fang HS; Li X; Ding Y; Fan QH; Zhang ZH; Wei YZ; Gong QX
    Genes Chromosomes Cancer; 2020 Oct; 59(10):595-600. PubMed ID: 32447786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern.
    Kao YC; Suurmeijer AJH; Argani P; Dickson BC; Zhang L; Sung YS; Agaram NP; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2020 Oct; 59(10):575-583. PubMed ID: 32506523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary NTRK-rearranged Spindle Cell Neoplasm of the Lung: A Clinicopathologic and Molecular Analysis of 3 Cases.
    Zhu P; Wang J
    Am J Surg Pathol; 2022 Jul; 46(7):1007-1013. PubMed ID: 35220354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 expression in an emerging group of mesenchymal spindle cell neoplasms with ALK fusion detected by flow cytometry and immunohistochemistry.
    Iwakoshi A; Kikui H; Nakashima R; Goto Y; Ichikawa D; Sasaki E; Sekimizu M; Hattori H; Maeda N
    Genes Chromosomes Cancer; 2024 Feb; 63(2):e23228. PubMed ID: 38380728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and Neck Mesenchymal Tumors with Kinase Fusions: A Report of 15 Cases With Emphasis on Wide Anatomic Distribution and Diverse Histologic Appearance.
    Xu B; Suurmeijer AJH; Agaram NP; Antonescu CR
    Am J Surg Pathol; 2023 Feb; 47(2):248-258. PubMed ID: 36638315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H; Xue X; Ding H; Ou Q; Wu X; Nagasaka M; Shao YW; Hu X; Ou SI
    Clin Lung Cancer; 2020 May; 21(3):247-254. PubMed ID: 31761448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.